Home
CA LÂM SÀNG
Issue: Số 69 (2015)
Article
Hoàng Bùi Hải: Bệnh viện Đại học Y Hà Nội;
Published: April 1, 2015
Views: 44
References
1.
1. International Commission of Radiological Protection. Pregnancy and medical radiation: Publication 84. Ann ICRP 2000;30:1–44.
2.
2. Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2_suppl):1S. doi:10.1378/chest.1412
3.
3. Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study direct fetal blood sampling under ultrasound. Throm rest 1984; 34:557
4.
4. Forrestier F, Daffos F, Rainaut M, Toulemonde F (1987), “Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy”. Thromb Haemost; 57:234
5.
5. Greer IA, Nelson-Piercy C (2005), “Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy”. Blood; 106:401.
6.
6. James A (2011), “Committee on Practice Bulletins-Obstetrics. Practice bulletin no.123: thromboembolism in pregnancy”. Obstet Gynecol; 118:718.
7.
7. David R Schwartz; Atul Malhotra; Steven E Weinberger, “Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment”; Jul 2014. This topic last updated: Jul 09, 2014.
8.
8. Turrentine MA1, Braems G, Ramirez MM (1995). Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. Jul;50(7):534-41.
9.
9. Torbicki A, Perrier A, Konstantinides S et al (2008), “Guidelines on the diagnosis and management of acute pulmonary embolism”. European Heart Journal 29, 2276–2315. doi: 10.1093/eurheartj/ehn310. Epub 2008 Aug 30.